TGFB1 and neoplasm: In the tumor ascites microenvironment, TGF-β reduces CD16 expression, thereby attenuating NK-mediated ADCC (13), and simultaneously inhibits the JAK-STAT and MAPK cascades essential for NK cell stimulation (14).